Clinical effectiveness of telehealth remote patient monitoring on glycemic control in type 1 and type 2 diabetes: a prospective multicenter study

BACKGROUND: There has been an increasing focus on the use of digital systems for remote monitoring (RM) of patient health recently.

AIM: To evaluate the clinical effectiveness of the RM system in patients with type 1 and type 2 diabetes (T1D and T2D) compared to traditional outpatient care.

MATERIALS AND METHODS: a non-randomized prospective open comparative multicenter study with parallel groups was conducted in 7 regions of the Russian Federation from March to September 2024. The study included patients with T1D, T2D on non-insulin therapy, and T2D on insulin therapy. The intervention group used a glycaemia RM system, which included a glucometer with a data transmission set, a mobile application that received data from the glucometer via Bluetooth technology, and a data transmission system for the doctor. In the control group, glycemia was assessed as part of routine clinical practice (in-person visits with a self-monitoring diary).

RESULTS: A total of 1,572 patients were included in the study. After a 180-day follow-up, the overall completion rate was 48% (754 patients). The primary endpoint, HbA1c levels, decreased comparably in the RM and control groups in patients with T1DM and in both cohorts of patients with T2DM. The proportion of individuals who achieved HbA1c target values was higher in the RM group compared to the control group in patients with T1DM (26.06% vs. 10.91%, respectively, p=0.023) and T2DM on non-insulin therapy (51.5% vs. 33%, respectively, p=0.003). RM use was associated with a reduction in unscheduled medical interventions.

CONCLUSION: RM has shown clinical efficacy in increasing the proportion of patients achieving HbA1c target values in the group of patients with T1D and T2D on non-insulin antidiabetic therapy.

1. Dedov II, Shestakova MV, Sukhareva OY, et al. Standards of Specialized Diabetes Care / Edited by Dedov I.I., Shestakova M.V., Sukhareva O.Yu. 12th Edition. Diabetes mellitus. 2025;28(5S):1-175. (In Russ.) doi: https://doi.org/10.14341/DM20255S

2. IDF Diabetes Atlas 11th edition. Available at https://diabetesatlas.org/resources/idf-diabetes-atlas-2025/

3. Almutairi N, Vlahu-Gjorgievska E, Win KT. Persuasive features for patient engagement through mHealth applications in managing chronic conditions: A systematic literature review and meta-analysis. Inform Health Soc Care. 2023;48(3):267-291. doi: https://doi.org/10.1080/17538157.2023.2165083

4. Eberle C, Löhnert M, Stichling S. Effectiveness of DiseaseSpecific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review. JMIR Mhealth Uhealth. 2021;9(2):e23477. doi: https://doi.org/10.2196/23477

5. Chichkova VV, Shapovalova MA, Chichkova MA, Antsiferov MB. Organization of outpatient care for patients with diabetes mellitus in the context of the COVID-19 pandemic using telemedicine technologies. Diabetes mellitus. 2023;26(4):334-342. (In Russ.) doi: https://doi.org/10.14341/DM13019

6. Laptev DN, Emelyanov AO, Titovich EV, et al. Features of telemedicine in monitoring of pediatric patients with newly diagnosed type 1 diabetes mellitus. Pediatria n.a. G.N. Speransky. 2022;101(5):8-14. (In Russ.) doi: https://doi.org/10.24110/0031-403X-2022-101-5-8-14

7. de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of longterm illnesses. Cochrane Database Syst Rev. 2012;12(12):CD007459. doi: https://doi.org/10.1002/14651858.CD007459.pub2

8. Tchero H, Kangambega P, Briatte C, et al. Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials. Telemed J E Health. 2019;25(7):569-583. doi: https://doi.org/10.1089/tmj.2018.0128

9. Dedov II, Shestakova MV, Majorov Ayu, i dr. Saharnyj diabet 2 tipa u vzroslyh. Klinicheskie rekomendacii Rossijskoj associacii endokrinologov. — 2022 (In Russ.) https://cr.minzdrav.gov.ru/preview-cr/290_2

10. Dedov II, Shestakova MV, Majorov Ayu, i dr. Saharnyj diabet 1 tipa u vzroslyh. Klinicheskie rekomendacii Rossijskoj associacii endokrinologov. — 2022 (In Russ.) https://cr.minzdrav.gov.ru/preview-cr/286_2

11. Suratham S, Klainin-Yobas P. The Effectiveness of Telehealth on Glycemic Stability and Quality of Life Among Patients With Type 1 and Type 2 Diabetes: A Systematic Review and MetaAnalysis. Sci Diabetes Self Manag Care. 2025;51(6):674-698. doi: https://doi.org/10.1177/26350106251378717

12. Hu Y, Wen X, Wang F, et al. Effect of telemedicine intervention on hypoglycaemia in diabetes patients: A systematic review and meta-analysis of randomised controlled trials. J Telemed Telecare. 2019;25(7):402-413. doi: https://doi.org/10.1177/1357633X18776823

13. Mathioudakis N, Lalani B, Abusamaan MS, et al. An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial. JAMA. 2025;334(23):2079-2089. doi: https://doi.org/10.1001/jama.2025.19563

14. Michaud TL, Ern J, Scoggins D, Su D. Assessing the Impact of Telemonitoring-Facilitated Lifestyle Modifications on Diabetes Outcomes: A Systematic Review and Meta-Analysis. Telemed J E Health. 2021;27(2):124-136. doi: https://doi.org/10.1089/tmj.2019.0319

15. Hangaard S, Laursen SH, Andersen JD, et al. The Effectiveness of Telemedicine Solutions for the Management of Type 2 Diabetes: A Systematic Review, Meta-Analysis, and MetaRegression. J Diabetes Sci Technol. 2023;17(3):794-825. doi: https://doi.org/10.1177/19322968211064633

16. Udsen FW, Hangaard S, Bender C, et al. The Effectiveness of Telemedicine Solutions in Type 1 Diabetes Management: A Systematic Review and Metaanalysis. J Diabetes Sci Technol. 2023;17(3):782-793. doi: https://doi.org/10.1177/19322968221076874

17. Azevedo RFL, Varzino M, Steinman E, Rogers WA. Evaluating Effectiveness of mHealth Apps for Older Adults With Diabetes: Meta-Analysis of Randomized Controlled Trials. J Med Internet Res. 2025;27:e65855. doi: https://doi.org/10.2196/65855